Evaluation of Thrombocytopenia in Patients Treated with Rhenium-186-HEDP: Guidelines for Individual Dosage Recommendations

A potential limitation of rhenium-186-1,1-hydroxyethylidene diphosphonate (186Re-HEDP) therapy in patients with painful bone metastases is thrombocytopenia. Given the palliative character of this therapy, it is essential to be able to predict the degree of thrombocytopenia before therapy. Thus far,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of nuclear medicine (1978) 1994-09, Vol.35 (9), p.1423
Hauptverfasser:	de Klerk, John M.H, van het Schip, Alfred D, Zonnenberg, Bernard A, van Dijk, Aalt, Stokkel, Marcel P.M, Han, Shiuw H, Blijham, Geert H, van Rijk, Peter P
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Bone Neoplasms - radiotherapy Bone Neoplasms - secondary Dose-Response Relationship, Radiation Etidronic Acid - therapeutic use Humans Male Middle Aged Platelet Count - radiation effects Prostatic Neoplasms - pathology Radioisotopes - adverse effects Radioisotopes - therapeutic use Rhenium - adverse effects Rhenium - therapeutic use Thrombocytopenia - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!